0.4582
price down icon0.87%   -0.004
after-market Handel nachbörslich: .44 -0.0182 -3.97%
loading

Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten

pulisher
10:59 AM

RNAZ stock touches 52-week low at $0.43 amid sharp annual decline - Investing.com

10:59 AM
pulisher
Apr 02, 2025

TransCode Therapeutics Inc’s Stock Price Plummeted Recently, But There Might Be Trouble Ahead - stocksregister.com

Apr 02, 2025
pulisher
Mar 31, 2025

TransCode Therapeutics Delays Annual Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

TransCode Therapeutics (RNAZ) Expected to Announce Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Emerging Tech QuartetPRSO, LXRX, PRTG, RNAZDrive - openPR.com

Mar 28, 2025
pulisher
Mar 28, 2025

Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews

Mar 28, 2025
pulisher
Mar 28, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

TransCode Therapeutics stock slides after announces to raise $10M securities offering - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

(RNAZ) Investment Analysis - news.stocktradersdaily.com

Mar 28, 2025
pulisher
Mar 27, 2025

Small Cap Stocks To Follow TodayMarch 23rd - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

TransCode Therapeutics, Inc. Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial Withttx-Mc138 - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

TransCode Therapeutics Starts Dosing for Experimental Cancer Treatment in Early Trial - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 27, 2025
pulisher
Mar 25, 2025

TransCode's $10M Capital Raise Powers Critical Cancer Drug Clinical Trials - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Transcode Therapeutics stock hits 52-week low at $0.64 By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

TransCode Therapeutics Announces $10M Stock And Warrant Offering - Nasdaq

Mar 24, 2025
pulisher
Mar 24, 2025

Sector Update: Health Care Stocks Rise Late Afternoon - TradingView

Mar 24, 2025
pulisher
Mar 24, 2025

Transcode Therapeutics stock hits 52-week low at $0.64 - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Transcode to sell 10.25M shares at 98c per share in registered direct offering - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

TransCode Therapeutics Starts $10 Million Direct Offering of Stock, Warrants -March 24, 2025 at 03:42 am EDT - Marketscreener.com

Mar 24, 2025
pulisher
Mar 23, 2025

$10M Capital Raise: TransCode Therapeutics Accelerates TTX-MC138 Clinical Trials - Stock Titan

Mar 23, 2025
pulisher
Mar 23, 2025

TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - PR Newswire

Mar 23, 2025
pulisher
Mar 22, 2025

Small Cap Stocks To ResearchMarch 21st - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025
pulisher
Mar 17, 2025

(RNAZ) Long Term Investment Analysis - Stock Traders Daily

Mar 17, 2025
pulisher
Mar 15, 2025

HC Wainwright Reaffirms “Buy” Rating for TransCode Therapeutics (NASDAQ:RNAZ) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

RNAZ stock touches 52-week low at $0.69 amid sharp annual decline - Investing.com Canada

Mar 14, 2025
pulisher
Mar 14, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138 - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 14, 2025
pulisher
Mar 13, 2025

TransCode Therapeutics Advances Phase I Trial Of RNA Cancer Therapy - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Transcode Therapeutics’ fourth cohort in Phase 1/2 cancer trial approved - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial - Longview News-Journal

Mar 13, 2025
pulisher
Mar 12, 2025

Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews

Mar 12, 2025
pulisher
Mar 10, 2025

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care - Cancer Network

Mar 10, 2025
pulisher
Mar 07, 2025

Transcode Therapeutics stock hits 52-week low at $1.7 By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 06, 2025

Transcode Therapeutics stock hits 52-week low at $1.7 - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Pre-market Movers: PRFX, BJDX, TARA, PBM... - RTTNews

Mar 06, 2025
pulisher
Mar 03, 2025

The Significance of Moving Averages in TransCode Therapeutics Inc Inc. (RNAZ) Price Performance - The InvestChronicle

Mar 03, 2025
pulisher
Feb 27, 2025

Transcode Therapeutics stock hits 52-week low at $2.62 By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Transcode Therapeutics stock hits 52-week low at $2.62 - Investing.com

Feb 27, 2025
pulisher
Feb 25, 2025

United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK

Feb 25, 2025
pulisher
Feb 25, 2025

TransCode Therapeutics, Inc. Announces Results of Special Meeting - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn

Feb 25, 2025
pulisher
Feb 25, 2025

Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast - Benzinga India

Feb 25, 2025
pulisher
Feb 24, 2025

Learn to Evaluate (RNAZ) using the Charts - Stock Traders Daily

Feb 24, 2025
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):